• Reducing pain in certain forms of obstetric pathology: nonsteroidal anti-inflammatory drugs (Сlinical lecture)

Reducing pain in certain forms of obstetric pathology: nonsteroidal anti-inflammatory drugs (Сlinical lecture)

HEALTH OF WOMAN.2017.6(122):9–14; doi 10.15574/HW.2017.122.9

Nazarenko L.
Kharkiv medical Academy of postgraduate education MH of Ukraine

The article discusses the pathogenetic basis for the use of non-steroidal anti-inflammatory drugs (NSPVP) in obstetric practice for the treatment of pain syndrome in women with threatened abortion and pathological preliminary period. Provided with modern views on the mechanisms of analgesic clinical efficacy, side effects NSPVP. Provides information about the place of NSPVP during pregnancy, the risks to the fetus, the positive aspects in the conduct of women at risk of preterm birth, the pathological preliminary period.

Key words: nonsteroidal anti-inflammatory drug, pain, premature birth, preliminary period.

REFERENCES

1. Shvetsov MV, Startseva NV. 2003. Ugroza nevyinashivaniya beremennosti: psihoterapevticheskie i meditsinskie podhodyi (reshenie problemyi). Perm:276.

2. Beecher HK. 1955, December 24. The Powerful Placebo. Journal of the American Medical Association. 159;17.

3. Nasonov EL. 2000. Nesteroidnyie protivovospalitelnyie preparatyi (Perspektivy primeneniya v meditsine). M, Izd-vo Anko:143.

4. Abramchenko VV, Proshyan AP. 2005. Nesteroidnyie protivovospalitelnye sredstva v akusherstve i ginekologii. SPb, Elbi:316.

5. Hernandez RK, Werler MM, Romitti P et al. 2012. Nonsteroidal antiinflammatory drug use among women and the risk of birth defects. Am. J. Obstet. Gynecol. 206; 3:228.e1–228.e8. https://doi.org/10.1016/j.ajog.2011.11.019; PMid:22196851

6. Marsh CA, Cragan JD, Alverson CJ et al. 2014. Case-control analysis of maternal prenatal analgesic use and cardiovascular malformations: Baltimore–Washington Infant Study Courtney. Am J Obstet Gynecol. 211;4: 404.e1–404.e9. https://doi.org/10.1016/j.ajog.2014.03.054; PMid:24681289 PMCid:PMC4406339

7. Atad J, David A, Moise J, Abramovici H. 1980. Classification of threatened premature labor related to treatment with a prostaglandin inhibitor: indomethacin. Biol. Neonate. 37:291–296. https://doi.org/10.1159/000241289; PMid:7388083

8. Stika CS, Gross GA, Leguizamon G et al. 2002. A prospective randomized safety trial of celecoxib for treatment of preterm labor. 187; 3:653–660. https://doi.org/10.1067/mob.2002.125281

9. Bivins HA Jr, Newman RB, Fyfe DA et al. 1993. Randomized comparative trial of indomethacin and terbutaline forthe long term treatment of preterm labor. Am. J. Obstet. Gynecol. 168:375. https://doi.org/10.1016/S0002-9378(12)90690-0

10. Cabrol D, Landesman R, Muller J et al. 1987. Treatment of polyhydramnios with prostaglandin synthetase inhibitor (indomethacin). Am. J. Obstet. Gynecol. 157:422–426. https://doi.org/10.1016/S0002-9378(87)80185-0

11. Hammers AL, Sanchez-Ramos L, Kaunitz AM. 2015. Antenatal exposure to indomethacin increases the risk of severe intraventricular hemorrhage, necrotizing enterocolitis, and periventricular leukomalacia: a systematic review with metaanalysis. Am. J. Obstet. Gynecol. 212; 4:505.e1–505.e13. https://doi.org/10.1016/j.ajog.2014.10.1091; PMid:25448524

12. De Wit W, Van Mourik I, Wiesenhaan PF. 1988. Prolonged maternal indomethacin therapy associated with oligohydramnios: case reports. Br. J. Obstet. Gynecol. 95:303–305. https://doi.org/10.1111/j.1471-0528.1988.tb06874.x

13. Kirshon B, Mari G, Moise KJ Jr. 1990. Indomethacin therapy in the treatment of symptomatic polyhydramnios. Obstet. Gynecol. 75:202–205. PMid:2405320

14. Refuerzo J. 2015. Liposomes a nanoscale drug carrying system to prevent indomethacin passage to the fetus in a pregnant mouse model. Am. J. Obstet. Gynecol. 212:508.e1-7. https://doi.org/10.1016/j.ajog.2015.02.006; https://doi.org/10.1016/j.ajog.2014.10.100

15. Rac VE, Small K, Scott CA et al. 2006, Aug. Meloxicam effectively inhibits preterm labor uterine contractions in a chronically catheterized pregnant sheep model: Impact on fetal blood flow and fetal-maternal physiologic parameters. Am. J. Obstet. Gynecol. 195;2:528–534. https://doi.org/10.1016/j.ajog.2006.02.011; PMid:16626612

16. Sidorova IS. 2006. Fiziologiya i patologiya rodovoy deyatelnosti. M, MIA:240.

17. Proshyan AP. 2006. Kliniko-eksperimentalnaya otsenka effektivnosti nesteroidnyih protivovospalitelnyih preparatov v terapii patologicheskogo preliminarnogo peri oda. Diss. kand. med. nauk. 14.00.01 Akusherstvo i ginekologiya. Sankt-Peterburg.

18. McCormack K, Brune K. 1991. Dissociation between the antinociceptive and antiinflammatory effects of the non-steroidal antiinflammatory drugs. Drugs. 41:533–547. https://doi.org/10.2165/00003495-199141040-00003; PMid:1711958

 

 

Содержание журнала Full text of article